Mr. Boms has more than 30 years of experience in leadership, management, and commercialization of innovative medical devices in the area of interventional cardiology and urology.
In 1991, Mr. Boms founded DDM (Diseno y Desarrollo Medico S.A de C.V). DDM is a high-tech medical device company focused on providing superior services in Latin America. DDM currently serves more than 200 cath labs and over 500 interventional cardiologists who serve the Mexican population of approximately 120 million people. Mr. Boms and DDM aim to help people heal people, and in the early 90’s he launched a unique educational program which included technical procedural training and support, sharing the clinical experience of experienced physicians with the Latin American interventional cardiology market.
Mr. Boms also visioned and assisted in the creation of the society for interventional cardiology called SOLACI, Sociedad Latinoamericana De Cardiologia Intervecionista.
Mr. Macias has more than 24 years of experience at DDM group in Mexico as a medical devices expert serving the private and public healthcare institutions. the group is specializing in Cardiology, Radiology, Neuroradiology and Spine Surgery.
In 2015 he became a member of the Board of Directors for Cardia, Inc., a company specializing in percutaneous closure of ASD’s (Atrial Septal Defect) and PFO’s (Patent Foramen Ovale) devices.
In 1999 Fausto was appointed as the CEO of DDM’s group. Since then, he founded several nationwide branches in Monterrey, Guadalajara, San Luís Potosí, Hermosillo among others.
Fausto launched advanced High-quality technology in Mexico and managed clinical protocols for products that received Ministry of Health registration leading to FDA approval.
Dr. Belson completed his Pediatric Nephrology fellowship at Stanford University Medical Center and spent one year as a research fellow with the Biomedical Technology Innovation Program at Stanford.
Dr. Belson founded NeoGuide Systems, a company that developed a platform technology for minimally invasive surgical procedures, that was acquired by Intuitive Surgical in 2009.
Dr. Belson founded Vascular Pathways, a company that developed an FDA cleared vascular intervention technology, that was acquired by C.R. Bard in 2015.
Dr. Belson also founded Qool, Zipline, Emboline, and Radiaction.